Stay updated with breaking news from Biolase inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Research analysts at StockNews.com initiated coverage on shares of BIOLASE (NASDAQ:BIOL – Get Free Report) in a research report issued to clients and investors on Tuesday. The firm set a “sell” rating on the medical technology company’s stock. Separately, Benchmark reaffirmed a “speculative buy” rating and set a $0.40 target price on shares of BIOLASE […] ....
BIOLASE, Inc. (NASDAQ:BIOL) Short Interest Up 474.9% in May dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.
BIOLASE, Inc. (NASDAQ:BIOL – Get Free Report) was the target of a significant growth in short interest in the month of May. As of May 15th, there was short interest totalling 1,670,000 shares, a growth of 474.9% from the April 30th total of 290,500 shares. Currently, 5.2% of the company’s shares are sold short. Based […] ....
Benchmark reiterated their speculative buy rating on shares of BIOLASE (NASDAQ:BIOL – Free Report) in a report released on Tuesday, Benzinga reports. Benchmark currently has a $0.40 target price on the medical technology company’s stock. Separately, StockNews.com started coverage on BIOLASE in a research note on Sunday, May 12th. They issued a sell rating for […] ....
BIOLASE : Failure to Satisfy Listing Rule - Form 8-K marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.